Intellectual Property Patent Trademark and Copyright Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks. As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property. Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews. Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues. The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding. Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC). The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review. Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review.

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date	Title	Organization
16 Oct	CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”?	Schwegman, Lundberg & Woessner, P.A.
15 Oct	Trade Secret Misappropriation: Denial of Motion for Attorneys’ Fees under CUTSA is Not an Appealable Order	Sheppard, Mullin, Richter & Hampton LLP
15 Oct	AFCP 2.0 Extended: Your Mileage May Vary	Squire Patton Boggs (US) LLP
14 Oct	China’s National Intellectual Property Administration to Cease Issuing Paper Trademark Certificates	Schwegman, Lundberg & Woessner, P.A.
14 Oct	Authentication Claim Under Alice—A Two-Step Process	McDermott Will & Emery
14 Oct	Oh the Horror: No Work for Hire in Friday the 13th Screenplay	McDermott Will & Emery
14 Oct	Design Patent Prior Art Must Be From Same or Analogous Field as Claimed Article of Manufacture	McDermott Will & Emery
14 Oct	Party May Not Veil EU Individual’s Information under GDPR at the TTAB	McDermott Will & Emery
14 Oct	Ex Parte Reexamination Not Allowed After Failed IPR Challenge	McDermott Will & Emery
14 Oct	Failing to Address All Reasons for Noninfringement Renders Appeal Moot	McDermott Will & Emery
13 Oct	Intellectual Property — Can Our Creations Also Create? The DABUS AI System as a Named Inventor [PODCAST]	Mintz
12 Oct	Cloudflare’s Silver Lining: It Is Not Contributorily Liable for Copyright Infringement	Finnegan
12 Oct	Multiple, Serial IPR Filings Doom Reexamination Request	Finnegan
11 Oct	Federal Circuit Allows Service by Alternative Means Under Rule 4(f)(3) in Patent Cases	Squire Patton Boggs (US) LLP
10 Oct	Shanghai, China’s Municipal People’s Congress Proposes Fining Irregular Patent Application Applicants Up To 150,000 RMB	Schwegman, Lundberg & Woessner, P.A.
9 Oct	Can Computer Systems Using Artificial Intelligence Patent their Own Inventions?	Cadwalader, Wickersham & Taft LLP
8 Oct	NYC vs Robert Lopez for His Cannabis-Themed Marks	Norris McLaughlin P.A.
7 Oct	No Immunity: State Right of Publicity Law is § 230 “Law Pertaining to Intellectual Property”	McDermott Will & Emery
7 Oct	Only One More Ratification Needed: European UPC Might Be Ready to Launch	McDermott Will & Emery
7 Oct	Induced Infringement Finding May Support Willfulness Finding	McDermott Will & Emery